These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2009-016932-11 Phase III randomized trial with neoadjuvant chemotherapy (TAC) with or without zoledronic acid for patients with HER2-negative breast cancer. not-yet-due
Other 2013-001484-23 Biomarker discovery randomized phase IIb trial with carboplatin-cyclophosphamide versus paclitaxel with or without atezolizumaB as first-line treatment in advanced triple negative Breast cancer not-yet-due
Ongoing 2013-001863-21 Optimizing neoadjuvant systemic treatment in HER2 positive breast cancer - the TRAIN-2 study not-yet-due
Not reported Terminated 2016-005210-22 Explorative trial to identify the impact of denosumab on the systemic immunity and local immunologic microenvironment in postmenopausal patients with HER2 negative breast cancer. Exploratieve studi... 2018-10-11 due-trials
Ongoing 2017-000676-29 Tailoring neoadjuvant therapy in hormone receptor positive, HER2 negative, luminal breast cancer. Neoadjuvante therapie op maat in hormoon receptor positieve, HER2 negatieve, luminale borstkanker. not-yet-due